Allergena Pet Dander
NDC 62713-101, Homeopathic Sublingual Immunotherapy, liquid, from Meditrend, Inc. DBA Progena Professional Formulations.
- Product NDC
- 62713-101
- Status
- Listed
- Labeler
- Meditrend, Inc. DBA Progena Professional Formulations
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62713-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BOS TAURUS ADRENAL GLAND4 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA3 [hp_X]/mL
- MAMMAL LIVER12 [hp_X]/mL
- CORTICOTROPIN30 [hp_X]/mL
- HISTAMINE12 [hp_X]/mL
- FELIS CATUS DANDER100 [hp_X]/mL
- CANIS LUPUS FAMILIARIS DANDER100 [hp_X]/mL
- EQUUS CABALLUS DANDER100 [hp_X]/mL
- BOS TAURUS DANDER100 [hp_X]/mL
- MUS MUSCULUS SKIN100 [hp_X]/mL
- MESOCRICETUS AURATUS SKIN100 [hp_X]/mL
- CAVIA PORCELLUS DANDER100 [hp_X]/mL
- ORYCTOLAGUS CUNICULUS SKIN100 [hp_X]/mL
- SUS SCROFA DANDER100 [hp_X]/mL
- CHICKEN100 [hp_X]/mL
- DUCK100 [hp_X]/mL
- GOOSE100 [hp_X]/mL
- BAPTISIA TINCTORIA3 [hp_X]/mL
- GOLDENSEAL3 [hp_X]/mL
- MYRRH3 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT3 [hp_X]/mL
- FENUGREEK SEED3 [hp_X]/mL
Pharmacologic classes
Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Cells, Epidermal [EXT]; Dander [CS]; Dander [CS]; Dander [CS]; Dander [CS]; Dietary Proteins [CS]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Animal Dander Allergenic Extract [EPC]; Non-Standardized Animal Dander Allergenic Extract [EPC]; Non-Standardized Animal Dander Allergenic Extract [EPC]; Non-Standardized Animal Dander Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Poultry Proteins [EXT]; Poultry Proteins [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62713-101-01 | 62713010101 | 30 mL in 1 BOTTLE, DROPPER (62713-101-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62713-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62713-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62713-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.